Components of Radiologic Progressive Disease Defined by RECIST 1.1 in Patients with Metastatic Clear Cell Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Components of Radiologic Progressive Disease Defined by RECIST 1.1 in Patients with Metastatic Clear Cell Renal Cell Carcinoma

Published:2019-07 Issue:1 Volume:292 Page:103-109
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Coy Heidi J.^ORCID,Douek Michael L.,Ruchalski Kathleen^ORCID,Kim Hyun J.^ORCID,Gutierrez Antonio^ORCID,Patel Maitrya^ORCID,Sai Victor,Margolis Daniel J. A.^ORCID,Kaplan Andrew,Brown Matthew^ORCID,Goldin Jonathan,Raman Steven S.^ORCID

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.2019182922

Reference35 articles.

1. RECIST — learning from the past to build the future

2. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

3. Blinded independent central review of progression in cancer clinical trials: Results from a meta-analysis

4. Pearls and pitfalls of response evaluation criteria in solid tumors (RECIST) v1.1 non-target lesion assessment

5. The components of progression as explanatory variables for overall survival in the Response Evaluation Criteria in Solid Tumours 1.1 database

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pooled Rate of Pseudoprogression, Patterns of Response, and Tumor Burden Analysis in Patients Undergoing Immunotherapy Oncologic Trials for Different Malignancies;Clinical Oncology;2024-10

2. Reproducing RECIST lesion selection via machine learning: Insights into intra and inter-radiologist variation;European Journal of Radiology Open;2024-06

3. How Does Target Lesion Selection Affect RECIST? A Computer Simulation Study;Investigative Radiology;2023-11-03

4. Do Imaging Core Laboratories Better Predict Progression Over Clinical Interpretations?;Radiology: Imaging Cancer;2023-09-01

5. RECIST 1.1 Target Lesion Categorical Response in Metastatic Renal Cell Carcinoma: A Comparison of Conventional versus Volumetric Assessment;Radiology: Imaging Cancer;2023-09-01